Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurodegenerative Diseases 1Ischemic Stroke 1Hemorrhagic Stroke 1Central Nervous System Vascular Malformations 1Central Nervous System Infections 1Brain Neoplasms 1Brain Injuries 1

Interventions

Cyclophosphamide 955Radiotherapy 847Cisplatin 756Gemcitabine 657Carboplatin 602Docetaxel 598Paclitaxel 585Bevacizumab 579Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 423Etoposide 410Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 327Leucovorin 305Nivolumab 295fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Blood Specimen Collection 279Peripheral Blood Stem Cell Transplantation 278Methotrexate 276Lenalidomide 276Cetuximab 269

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER × Tissue Array Analysis × Clear all
NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡